Vor Biopharma
VOR
VOR
45 hedge funds and large institutions have $43.1M invested in Vor Biopharma in 2025 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 18 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
-7
Holders Change %
-13.46%
% of All Funds
0.61%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
9
Increased
9
Reduced
18
Closed
16
Calls
$28K
Puts
$7K
Net Calls
+$21K
Net Calls Change
-$44K
Top Buyers
Top Sellers
| 1 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
-$707K |
| 2 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
-$366K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$222K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$95K |
| 5 |
Morgan Stanley
New York
|
-$89.3K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
LP
51
LMR Partners
London,
United Kingdom
| – | -$56.7K | -51,111 | Closed |
|
|
PAS
52
Point72 Asia (Singapore)
Singapore
| – | -$31.2K | -28,090 | Closed |
|
53
Two Sigma Advisers
New York
| – | -$30.5K | -27,500 | Closed |
|
|
CSS
54
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$17.9K | -16,102 | Closed |
|
|
TSS
55
Two Sigma Securities
New York
| – | -$11.2K | -10,069 | Closed |
|
|
WS
56
Wedbush Securities
Los Angeles,
California
| – | -$11K | -10,000 | Closed |
|
|
EBA
57
Eagle Bay Advisors
New York
| – | -$167 | -150 | Closed |
|
|
PD
58
Point72 (DIFC)
Dubai,
United Arab Emirates
| – | -$29 | -26 | Closed |
|
59
Citigroup
New York
| – | -$7 | -6 | Closed |
|
|
NS
60
NBC Securities
Birmingham,
Alabama
| – | -$1 | -1 | Closed |
|